Wunderman has been chosen to launch a consumer campaign for AstraZeneca’s breast cancer treatment Faslodex. Wunderman will handle DTP relationship marketing efforts aimed at raising awareness in late-stage breast cancer patients, as well as DTC efforts. A print campaign is slated for summer 2007.
From the May 01, 2007 Issue of MM+M - Medical Marketing and Media
